There are stories that make every parent stop cold.
This is one of them.
Families in Ladera Ranch, California, say six children from their community have been diagnosed with Ewing sarcoma, an extraordinarily rare cancer of bone and soft tissue.
One of those children, 17-year-old Brody Matteson, died in March.
No government agency has officially declared a cancer cluster or identified a common cause. But with a cancer this rare, the families’ questions cannot simply be waved away.
Cluster of extremely rare cancer cases suddenly strikes kids in wealthy SoCal city https://t.co/UgfldYsj9w pic.twitter.com/T2hugEZYsK
— California Post (@californiapost) July 9, 2026
NBC Los Angeles spoke with Brody’s mother, Megan Matteson, about the teenager her family lost. Her account puts a child and a grieving family behind numbers that can otherwise feel cold and distant.
She described Brody as an outdoor kid who rode his bike, built jumps, and spent time in the parks around Ladera Ranch.
Shortly before his 15th birthday, back pain led to a devastating diagnosis. The tumor was on the L4 vertebra of his spine, in a location his mother said could not be treated with surgery.
After Brody died, Matteson said she began hearing from other local families. The reports did not arrive through an official public notice; parents found one another as they confronted the same terrifying diagnosis.
Five other children in the community had reportedly been diagnosed with Ewing sarcoma. That brought the family-reported total to six.
Matteson said three families contacted her quickly after Brody’s diagnosis. Their support helped, but hearing the same devastating words attached to other children in a community of roughly 20,000 to 30,000 people was frightening.
NBC’s report did not identify all six children or independently publish their medical records. The total comes from Matteson’s account of the families who came forward.
NBC also reported that Orange County health officials conducted an initial review of cancer data and did not find a particular pattern. Because concerns have continued, officials said they plan to review the data again in the coming weeks.
That distinction matters. The concern is real, but the existence of an official cancer cluster has not yet been established.
Families in Ladera Ranch say they want answers as to why several children in their one community have all been diagnosed with the same rare cancer. https://t.co/kTNdZenGkg
— NBC Los Angeles (@NBCLA) July 9, 2026
The numbers explain why the reports have shaken this community so deeply.
The American Cancer Society says Ewing sarcoma is a rare tumor that develops in tissue that normally forms bone and soft tissue.
It accounts for only about 1% of childhood cancers. Roughly 200 children and teenagers are diagnosed across the entire United States each year.
Most Ewing tumors develop in teenagers, though the disease can also strike younger children and adults. Younger patients are more likely to develop tumors that begin in bone, while adults are more likely to have tumors outside the bones.
The cancer is also diagnosed more often in males than females. The American Cancer Society notes significant differences in incidence among racial groups, another factor investigators must consider when comparing a local population with national rates.
Those details are why a raw count cannot settle the question by itself. Public-health officials have to compare similar populations and measure the local reports against an appropriate expected rate.
The National Cancer Institute puts the incidence rate at approximately three cases per one million Americans younger than 20, based on federal registry data from 2016 through 2020.
The rate rises with age during childhood, reaching 4.3 cases per million among children ages 10 to 14 and 4.5 per million among teens ages 15 to 19.
NCI says the overall pediatric incidence has remained essentially unchanged from the rate reported between 1973 and 2004. That makes Ewing sarcoma persistently rare, not a disease whose national frequency has recently surged.
Those national statistics do not prove that six reported cases in Ladera Ranch form a cluster. They do show why parents are stunned to hear the same diagnosis repeated in one relatively small community.
The families are also asking for more information about pesticides used in shared outdoor spaces.
They have not claimed to know what caused the illnesses. In fact, an attorney working with the families told NBC that correlation is not causation and that they cannot say pesticides are responsible.
That caution is essential. There is currently no established evidence tying a specific landscaping product or community practice to these reported cases.
Still, asking what is being applied around parks, sidewalks, and other common areas is a reasonable question when parents are desperate for answers.
Ladera Ranch’s official pest-management page says its landscaping contractor uses fertilizers, pesticides, and herbicides in common areas. It says synthetic materials are sometimes used when practical alternatives are unavailable and that the products are approved for their intended use by the EPA and California Department of Pesticide Regulation.
The HOA says those materials are used to control invasive weeds, turf weeds, tree borers, and grubs that can damage the community’s landscaping.
Its page also says the contractor considers non-synthetic options but sometimes concludes that synthetic products are required to maintain common areas.
That is the association’s public explanation. The families’ request goes further: they want enough information about which products were used, where they were applied, and in what amounts to let investigators evaluate whether any shared exposure deserves scrutiny.
That policy is useful context. It is not proof of a cancer connection.
The right next step is not internet speculation. It is a transparent review of verified diagnoses, the affected population, the timeline, and any exposures the children may have shared.
The CDC defines a cancer cluster as a greater-than-expected number of the same or etiologically related cancers among a defined group of people, in a defined place, over a defined period.
That definition requires more than counting cases. Investigators must establish the population at risk, the geographic boundary, the time window, and the expected incidence for a comparable group.
The CDC also warns that an unusual pattern can result from chance, genetics, behavior, social factors, occupational exposure, environmental exposure, or a combination of influences.
Geography and time matter enormously. The agency notes that changing the boundaries of the area being studied can accidentally create or obscure an apparent cluster, while the chosen time period changes both the number of observed cases and the expected rate.
Cancer investigations are also complicated by latency, population movement, and the fact that multiple factors can interact in ways researchers do not fully understand.
That is why a careful investigation can neither begin with a predetermined culprit nor end with a shrug. It has to test the reported pattern against real data and follow the evidence from there.
In other words, public-health officials have serious work to do before anyone can responsibly announce either a cluster or a cause.
@Dr_R_Kurzrock thoughts on this? What’s the pattern for rare disease such as sarcoma? After her son died, Megan Matteson said she began hearing from other families in Ladera Ranch — a city of about 20,000 to 30,000 people — where she says five other children have been diagnosed…
— Sarcoma Southern California (@sarcsouthernca) July 9, 2026
Brody’s parents are not asking the public to pretend an answer already exists.
They are asking officials to do the work required to find out whether one does.
Six children in one community facing one of the rarest pediatric cancers is more than enough reason for sunlight, records, and a serious second review.
No panic. No premature verdict.
But no brush-off, either.
These families deserve clarity, and every parent in Ladera Ranch deserves to know that the questions are being pursued wherever the evidence leads.
Since the widespread rollout of the COVID-19 mRNA vaccines we have seen an alarming rise in cancer diagnoses. This is even more particularly pronounced among younger individuals, who are getting diagnosed with aggressive cancers at a concerning rate.
According to Dr. Peter McCullough, writing in his substack, the timing of these incidents is more than coincidental:
Since late 2022, independent oncologists and immunologists—such as Professor Angus Dalgleish of St. George’s, London, and Dr. Wafik El‑Deiry of Brown University—have warned of a surge in immunologic dysregulation following repeated mRNA injections. Peer‑reviewed analyses (Oncotarget, January 2026) describe “rapid progression or recurrence of previously indolent cancers” temporally linked to vaccination or severe COVID-19 infection. Mechanistically, both situations share key features: chronic inflammation, spike‑induced mitochondrial damage, depletion of cytotoxic T cells, suppression of p53/BRCA tumor‑surveillance pathways, and the infamous IgG4 class‑switch phenomenon that signals immune tolerance to pathogenic antigens. In other words, the body learns not to fight back.
The evidence is mounting that the culprit in these rising rates of cancer, particularly aggressive cancers, is connected to the deployment of the mRNA vaccines in 2021:
If spike exposure promotes tolerogenic or suppressive immune states, it effectively disables the very system responsible for preventing malignant transformation. This hypothesis not only fits the timeline—post‑2021 rises in aggressive cancers—but also accounts for why tumors in the young often present suddenly and advance fast enough to be called “turbo cancers.”
Despite the mounting evidence, much of the medical establishment and their handmaidens in the legacy media, refuse to acknowledge even the possibility of a link between the COVID-19 vaccines and cancer. As Dr. McCullough points out:
To acknowledge this connection would be to indict an entire biomedical complex that profited from both pandemic panic and mass inoculation. Regulatory agencies explicitly waived carcinogenicity testing for the mRNA products. Their emergency authorization was based on weeks—not years—of observation. Now the same institutions fund research asking whether microplastics or late pregnancies explain the cancer wave, as though a polymer fragment in a salad poses more biological disruption than billions of cells processing synthetic mRNA and producing a modified viral toxin inside the body.
The refusal to investigate spike biology as a carcinogenic catalyst is symptomatic of a deeper pathology: institutional capture. Pharmaceutical corporations bankroll most cancer research foundations; their executives rotate through public agencies that set the research agenda. If spike-induced oncogenesis were confirmed, it would open them to liability and moral outrage far beyond anything seen with tobacco or asbestos. Hence, the cultivated ignorance.
As Cancer Changes, So Must our Approach to Prevention
In this new reality of rising cancer rates and the increased prevalence of aggressive “turbo-cancers,” experts like Dr. McCullough are calling on Americans to consider new approaches to prevention:
Since 2021, global oncology trends have shifted significantly. Epidemiological data indicates a troubling, unexplained acceleration in cancer diagnoses, particularly among younger, likely COVID-19 vaccinated cohorts who historically presented lower risk profiles. This phenomenon has sparked intense debate regarding potential oncogenicity of genetic vaccines, Spike protein exposure, and other determinants. As the medical establishment struggles to contextualize these shifts, the necessity for proactive, non-invasive, and highly sensitive screening modalities has become a paramount concern for patients seeking to bypass institutional inertia.
The Promise of Ivermectin and Mebendazole
The off label use of anti-parasitic drugs like Ivermectin and Mebendazole is showing great promise in the potential to fight cancer.
Indeed, Dr. McCullough, and a number of his colleagues at The Wellness Company, have recently authored a first of its kind study of the application of Ivermectin+Mebendazole in the treatment of cancer.
In this human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer. These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.
The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6 months, participants reported an 84% Clinical Benefit Ratio. With 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression.
Cancer remains one of the leading causes of death globally, with conventional treatments such as chemotherapy, radiation therapy, and targeted agents frequently limited by significant toxicity, high cost, development of resistance, and variable long-term efficacy.
The experts at The Wellness Company undertook this study because ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited.
According to Dr. McCullough, “This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”
How You Can Get Ivermectin + Mebendazole
The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole, in a high-dose 90-day supply:
Ivermectin – Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision.
Mebendazole – Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family’s health and well-being with proven efficacy and safety.
Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.
What people are saying about The Wellness Company’s Ivermectin + Mebendazole:
I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. – Jennifer W.
My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physcian had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen
Order Ivermectin and Mebendazole from The Wellness Company today!
(Note: The information provided is intended for generalized informational purposes only and should not be considered personal medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications. Thank you for supporting businesses like the one presenting a sponsored message in this article and ordering through the links provided, which benefits WLTReport. We appreciate your support and the opportunity to keep you SAFE and HEALTY!)
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!